Cargando…
BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity
Epidemiological studies and clinical trials suggest Bacillus Calmette-Guérin (BCG) vaccine has protective effects against coronavirus disease 2019 (COVID-19). There are now over 30 clinical trials evaluating if BCG vaccination can prevent or reduce the severity of COVID-19. However, the mechanism by...
Autores principales: | Eggenhuizen, Peter J., Ng, Boaz H., Chang, Janet, Fell, Ashleigh L., Cheong, Rachel M. Y., Wong, Wey Y., Gan, Poh-Yi, Holdsworth, Stephen R., Ooi, Joshua D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374943/ https://www.ncbi.nlm.nih.gov/pubmed/34421902 http://dx.doi.org/10.3389/fimmu.2021.692729 |
Ejemplares similares
-
Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria
por: Eggenhuizen, Peter J., et al.
Publicado: (2022) -
Treg Enhancing Therapies to Treat Autoimmune Diseases
por: Eggenhuizen, Peter J., et al.
Publicado: (2020) -
Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2
por: Tarabini, Renata Fioravanti, et al.
Publicado: (2022) -
The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019) -
BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4(+) T Cells
por: Sathkumara, Harindra D., et al.
Publicado: (2019)